Home » Insights » ADC Symposium 2026: Interview with Flavien Susanne, VP Chemical development and clinical manufacturing, Astrazeneca

ADC Symposium 2026: Interview with Flavien Susanne, VP Chemical development and clinical manufacturing, Astrazeneca

ADC Symposium 2026 · Interview with Flavien Susanne

Insights from the ADC Symposium 2026

The ADC Symposium 2026, held in Prague on 16–17 September and organised by TKS event organiser, publisher of Chemistry Today, brought together experts from across the antibody-drug conjugate (ADC) field.

During the on-site event, the Chemistry Today team interviewed selected speakers and industry experts to explore some of the key challenges, developments and opportunities shaping ADC development and manufacturing.

We are now bringing these conversations to our readers through a new series of interviews.

Featured Interview

Flavien Susanne

VP Chemical Development and Clinical Manufacturing · AstraZeneca

Flavien Susanne shares his perspective on the growing complexity of drug-linker payload molecules and the challenges this creates for development and GMP manufacturing.

He also discusses the importance of bringing process chemistry, analytical development and manufacturing closer together earlier in the development process, as well as the potential of AI and automation to accelerate development and support a more agile approach to ADC manufacturing.

Discover more about the ADC Symposium, including the 2026 agenda and the latest event news.

Visit the ADC Symposium website →

The dates for the next edition will be announced soon.

Trusted by

40 years connecting the world of science for industry

Our journals:

Login